Clinical trials: OPCABG
Complication of Coronary Artery Bypass Graft, Complication of Extracorporeal Circulation
Combined Use of a Novel Cardioplegic Formula With MPS ® Using the MiECC in Isolated CABG Versus OPCABG
A patient group receiving a novel cardioplegic formula with MPS ® (Myocardial protection system) and using the MiECC (Minimal extracorporeal circulation system) when undergoing coronary artery bypass grafting is compared to a…
- Trial name
- OPCBAG (NCT03609723)
- Testing
- CABG
- Where
- Switzerland
- Volunteers
- 2,433 people
- Sponsor
- University Hospital, Basel, Switzerland